	Sep 2025	Jun 2025	Sep 2024	Change QoQ%	Change YoY%
Total Revenue Qtr	-0.10	1.54	-0.65	-106.5%	84.6%
Operating Profit Qtr	-0.39	1.34	-0.35	-129.1%	-11.4%
Net Profit Qtr	-0.49	1.34	-1.00	-136.6%	51.0%
Earning Per Share Adjusted latest Qtr	-0.01	0.01	-0.01	-200.0%	0.0%

* Standalone data

Detailed Results

Biogen Pharmachem Industries Ltd.

07 Nov 2025

0.73

2.82%

Board Meeting

Biogen Pharmachem Industries Ltd - 531752 - Board Meeting Outcome for Outcome Of The Board Meeting …

BSE India

Pursuant to Second proviso to Regulation 30(6) and Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 we hereby inform you that the Board of Directors of the Company, in their meeting held on today i.e. Friday 07th November 2025 at the Registered Office of the Company and transacted the following major businesses: 1.) Considered and approved Un-audited financial results for the quarter and half year ended as on 30th September, 2025. The board meeting commented at 03:30 PM and concluded at 04:00 PM Please take the above intimation in your records. Thanking You.

pdf

Biogen Pharmachem Industries Ltd.

30 Oct 2025

0.73

2.82%

Board Meeting

Biogen Pharmachem Industries Ltd - 531752 - Board Meeting Intimation for Compliance Of Regulation 29 Of …

BSE India

Biogen Pharmachem Industries Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/11/2025 ,inter alia, to consider and approve PFA

pdf